{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:24:42Z","timestamp":1793211882243,"version":"4.5.0"},"reference-count":12,"publisher":"American Psychiatric Association Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2003,2,1]]},"DOI":"10.1176\/appi.ajp.160.2.371","type":"journal-article","created":{"date-parts":[[2003,1,31]],"date-time":"2003-01-31T15:04:42Z","timestamp":1044025482000},"page":"371-373","source":"Crossref","is-referenced-by-count":500,"title":["Reduction of Nightmares and Other PTSD Symptoms in Combat Veterans by Prazosin: A Placebo-Controlled Study"],"prefix":"10.1176","volume":"160","author":[{"given":"Murray A.","family":"Raskind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine R.","family":"Peskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan D.","family":"Kanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Radant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorcas J.","family":"Dobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah J.","family":"Rein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy","family":"Straits-Tr\u00f6ster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald G.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles M.","family":"McFall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1602BABJCAFB","doi-asserted-by":"crossref","unstructured":"Raskind MA, Dobie DJ, Kanter ED, Petrie EC, Thompson CE, Peskind ER: The alpha-1 adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder. J Clin Psychiatry 2000; 61:129-133","DOI":"10.4088\/JCP.v61n0208"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Taylor F, Raskind MA: The alpha-1 adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder. J Clin Psychopharmacol 2002; 22:82-85","DOI":"10.1097\/00004714-200202000-00013"},{"key":"R1602BABEFCDI","doi-asserted-by":"crossref","unstructured":"Raskind MA, Thompson C, Petrie EC, Dobie DJ, Rein RJ, Hoff DJ, McFall ME, Peskind ER: Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder. J Clin Psychiatry 2002; 63:565-568","DOI":"10.4088\/JCP.v63n0705"},{"key":"R1602BABDGHJJ","doi-asserted-by":"crossref","unstructured":"Hieble JP, Ruffulo RR Jr: The use of alpha-adrenoreceptor antagonists in the pharmacological management of benign prostatic hypertrophy: an overview. Pharmacol Res 1996; 33:145-160","DOI":"10.1006\/phrs.1996.0022"},{"key":"R1602BABHBIAG","doi-asserted-by":"crossref","unstructured":"Geracioti TD Jr, Baker DG, Ekhator NN, West SA, Hill KK, Bruce AB, Schmidt D, Rounds-Kugler B, Yehuda R, Keck PE Jr, Kasckow JW: CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 2001; 158:1227-1230","DOI":"10.1176\/appi.ajp.158.8.1227"},{"key":"R1602BABHHGIF","doi-asserted-by":"crossref","unstructured":"Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM: The development of a Clinician-Administered PTSD Scale. J Trauma Stress 1995; 8:75-90","DOI":"10.1007\/BF02105408"},{"key":"R1602BABJJDJI","doi-asserted-by":"crossref","unstructured":"Penava SJ, Otto MW, Pollack MH, Rosenbaum JF: Current status of pharmacotherapy for PTSD: an effect size analysis of controlled studies. Depress Anxiety 1997; 4:240-242","DOI":"10.1002\/(SICI)1520-6394(1996)4:5<240::AID-DA6>3.3.CO;2-8"},{"key":"R1602BABJFBIH","doi-asserted-by":"crossref","unstructured":"Woodward SH, Arsenault NJ, Murray C, Bliwise DL: Laboratory sleep correlates of nightmare complaint in PTSD inpatients. Biol Psychiatry 2000; 48:1081-1087","DOI":"10.1016\/S0006-3223(00)00917-3"},{"key":"R1602BABDADAD","doi-asserted-by":"crossref","unstructured":"Pickworth WB, Sharpe LG, Nozaki M, Martin WR: Sleep suppression induced by intravenous and intraventricular infusions of methoxamine in the dog. Exp Neurol 1977; 57:999-1011","DOI":"10.1016\/0014-4886(77)90123-6"},{"key":"R1602BABIHEDC","doi-asserted-by":"crossref","unstructured":"Vynthilingam M, Anderson GM, Owens MJ, Halaszynski TM, Bremner JD, Carpenter LL, Heninger GR, Nemeroff CB, Charney DS: Cerebrospinal fluid corticotropin-releasing hormone in healthy humans: effects of yohimbine and naloxone. J Clin Endocrinol Metab 2000; 85:4138-4145","DOI":"10.1210\/jcem.85.11.6968"},{"key":"R1602BABEHHDC","doi-asserted-by":"crossref","unstructured":"Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, Southwick SM, Nemeroff CB, Charney DS: Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 1997; 154:624-629","DOI":"10.1176\/ajp.154.5.624"},{"key":"R1602BABDEEGI","doi-asserted-by":"crossref","unstructured":"Arnsten AF, Mathew R, Ubrian R, Taylor JR, Li BM: Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function. Biol Psychiatry 1999; 45:26-31","DOI":"10.1016\/S0006-3223(98)00296-0"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.2.371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T09:32:14Z","timestamp":1722159134000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.2.371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,1]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2,1]]}},"alternative-id":["10.1176\/appi.ajp.160.2.371"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.160.2.371","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,1]]}}}